Treatment of Hodgkin's disease.
Appropriate treatment of Hodgkin's disease results in an overall five-year cure rate of about 80 percent and a cure rate exceeding 90 percent in early-stage disease. No stage of disease is incurable, and patients can be cured even if they fail their first course of therapy. Radiation therapy remains the preferred treatment for early-stage disease, while chemotherapy is the primary treatment for advanced or recurrent disease. Combination of the two modalities is very effective in intermediate and advanced disease, but is associated with an increased risk of acute leukemia or non-Hodgkin's lymphoma.
D000970:Antineoplastic Agents / Q000009:adverse effects; D004359:Drug Therapy, Combination; D005260:Female; D006689:Hodgkin Disease / Q000150:complications / Q000175:diagnosis / Q000532:radiotherapy / Q000628:therapy*; D006801:Humans; D007938:Leukemia / Q000209:etiology; D008223:Lymphoma / Q000209:etiology; D008297:Male; D011379:Prognosis
D000970:Antineoplastic Agents